Literature DB >> 7535520

Plasma exudation in conscious dogs with experimental heart failure.

I Rubinstein1, G Müns, I H Zucker.   

Abstract

The purpose of this study was to determine the effects of bradykinin (BK), substance P (SP) and histamine on plasma exudation in the skin of conscious dogs with and without pacing-induced heart failure. We also determined the role tissue angiotensin I-converting enzyme (ACE) and neutral endopeptidase (NEP) play in modulating these responses. We found that intradermal injection of BK, SP and histamine induced a significant, concentration-dependent Evans blue exudation in normal dogs (p < 0.05). Bradykinin-induced responses were significantly potentiated by captopril (p < 0.05). In contrast, phosphoramidon potentiated BK-induced responses only at low concentrations of BK. Both captopril and phosphoramidon had no significant effects on SP- and histamine-induced Evans blue exudation. BK- and SP-induced responses were significantly attenuated, whereas histamine-induced Evans blue exudation was significantly potentiated in dogs with heart failure. We conclude that heart failure is associated with attenuation of BK- and SP-, but not histamine-induced plasma exudation in the peripheral microcirculation and that these responses are not modulated by tissue ACE and NEP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7535520     DOI: 10.1007/bf00788284

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  29 in total

Review 1.  Bioregulation of kinins: kallikreins, kininogens, and kininases.

Authors:  K D Bhoola; C D Figueroa; K Worthy
Journal:  Pharmacol Rev       Date:  1992-03       Impact factor: 25.468

2.  Simple method for quantitation of enhanced vascular permeability.

Authors:  K Udaka; Y Takeuchi; H Z Movat
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

Review 3.  Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture.

Authors:  E G Erdös
Journal:  Hypertension       Date:  1990-10       Impact factor: 10.190

4.  Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade.

Authors:  Y Yuan; H J Granger; D C Zawieja; D V DeFily; W M Chilian
Journal:  Am J Physiol       Date:  1993-05

5.  Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.

Authors:  K B Margulies; M A Perrella; L J McKinley; J C Burnett
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  Prolonged neutral endopeptidase inhibition in heart failure.

Authors:  K Helin; I Tikkanen; T Tikkanen; O Saijonmaa; E J Sybertz; S Vemulapalli; H Sariola; F Fyhrquist
Journal:  Eur J Pharmacol       Date:  1991-05-30       Impact factor: 4.432

7.  Morphological and physiological correlation of bradykinin-induced macromolecular efflux.

Authors:  E Svensjö; K E Arfors; R M Raymond; G J Grega
Journal:  Am J Physiol       Date:  1979-04

8.  Differences in plasma beta-endorphin and bradykinin levels between patients with painless or with painful myocardial ischemia.

Authors:  A Kurita; B Takase; A Uehata; H Sugahara; T Nishioka; T Maruyama; K Satomura; K Mizuno; H Nakamura
Journal:  Am Heart J       Date:  1992-02       Impact factor: 4.749

9.  Tissue angiotensin I-converting enzyme activity in spontaneously hypertensive hamsters.

Authors:  I Rubinstein; M Houmsse; R G Davis; J K Vishwanatha
Journal:  Biochem Biophys Res Commun       Date:  1992-03-31       Impact factor: 3.575

10.  Mast cell chymase potentiates histamine-induced wheal formation in the skin of ragweed-allergic dogs.

Authors:  I Rubinstein; J A Nadel; P D Graf; G H Caughey
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 19.456

View more
  3 in total

1.  Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.

Authors:  Andrew P Davie; John J V McMurray
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

Review 2.  Long-term neprilysin inhibition - implications for ARNIs.

Authors:  Duncan J Campbell
Journal:  Nat Rev Cardiol       Date:  2016-12-15       Impact factor: 32.419

Review 3.  Neprilysin Inhibitors and Bradykinin.

Authors:  Duncan J Campbell
Journal:  Front Med (Lausanne)       Date:  2018-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.